SEPSF — Asep Medical Holdings Inc.
—
OTC ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1969766 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 73,990 | 155 | -465,078 | -692,081 | 8,539,777 | 76,323 | 3,565,275 |
| Mar 2026 | 73,177 | 73,177 | -360,656 | -273,310 | 8,651,858 | 121,295 | 4,593,103 |
| Dec 2025 | 114,803 | 122,580 | -744,866 | -2,734,108 | 8,717,042 | 153,652 | 4,379,807 |
| Sep 2025 | 74,803 | 88,642 | -571,173 | -486,405 | 13,475,042 | 510,627 | 4,086,101 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-812,565
Investing CF
$749,373
Financing CF
$143,448
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.06
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-28,463,456
Inventory
—
Receivables
$13,294
ST Investments
—
EBIT TTM
$-5,834,692
Pretax Income TTM
$-5,864,512
Interest Exp TTM
$29,820
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$336,773
EBITDA
$-1,402,887
Free Cash Flow
$-862,859
Enterprise Value
$2,516,807
Total Cash
$215,226
Total Debt
$635,638
Shares Out
15,873,520
Trailing EPS
$-0.71
Book Value
$0.14
ROE
-88.1%
ROA
-11.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 336,773 | -2,564,092 | -4,915,865 | 8,717,042 | 4,379,807 | 2,327,286 | -1,017,846 |
| Dec 2023 | 21,140 | -7,721,263 | -8,227,328 | 25,612,686 | 3,051,861 | 12,611,990 | -2,712,598 |
| Dec 2022 | 0 | -5,442,652 | -4,524,981 | 27,078,589 | 528,161 | 15,469,999 | -3,614,476 |
| Dec 2021 | 0 | -1,977,625 | -2,200,086 | 30,716,132 | 144,204 | 18,259,194 | -1,191,064 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IQV | IQVIA HOLDINGS INC. | $42.50B | $258.21 | — |
| IDXX | IDEXX LABORATORIES INC /DE | $40.84B | $518.39 | — |
| INCY | INCYTE CORP | $23.37B | $115.30 | — |
| MEDP | Medpace Holdings, Inc. | $16.73B | $599.47 | — |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $13.98B | $290.19 | — |
Recent Insider Activity
No insider activity indexed for this ticker.